Quince Therapeutics, Inc. (QNCX) DCF Valuation

Quince Therapeutics, Inc. (QNCX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Quince Therapeutics, Inc. (QNCX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

As an investor or analyst, this [Symbol] DCF Calculator is your go-to resource for accurate valuation. Loaded with real data from Quince Therapeutics, Inc. (QNCX), you can adjust forecasts and immediately observe the effects.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -39.0 -78.6 -90.0 -52.0 -31.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .2 .3 .3 .2 .3 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -39.2 -78.9 -90.3 -52.2 -31.6 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 99.9 133.8 106.8 90.2 75.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 1.0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 2.2 2.3 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 3.1 3.6 4.9 .6 2.0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 -.1 -.2 -.1 -.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0.62377 0.62377 0.62377 0.62377 0.62377 0.62377 0.62377 0.62377 0.62377 0.62377
EBITAT -39.0 -78.9 -89.7 -51.9 -31.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -35.8 -78.1 -90.4 -56.2 -28.5 -1.0 .0 .0 .0 .0
WACC, % 7.27 7.27 7.26 7.26 7.26 7.27 7.27 7.27 7.27 7.27
PV UFCF
SUM PV UFCF -1.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -7
Equity Value 6
Diluted Shares Outstanding, MM 37
Equity Value Per Share 0.16

What You Will Receive

  • Comprehensive Financial Model: Quince Therapeutics' actual data facilitates accurate DCF valuation.
  • Complete Forecast Flexibility: Modify revenue growth, profit margins, discount rates, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Adaptable and Reusable: Designed for versatility, enabling repeated application for in-depth forecasts.

Key Features

  • Comprehensive Data: Quince Therapeutics’ historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Observe Quince Therapeutics’ intrinsic value update instantly.
  • Intuitive Visual Outputs: Dashboard graphs illustrate valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based QNCX DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Quince Therapeutics’ intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Utilize the results to inform your investment or financial decisions.

Why Choose This Calculator?

  • User-Friendly Interface: Perfect for both novice and experienced users.
  • Customizable Inputs: Tailor assumptions to suit your specific analysis needs.
  • Real-Time Feedback: Observe immediate updates to Quince Therapeutics’ valuation as you adjust the parameters.
  • Preloaded Data: Comes with Quince Therapeutics’ actual financial information for swift evaluations.
  • Relied Upon by Experts: A go-to tool for investors and analysts for making educated choices.

Who Should Use Quince Therapeutics, Inc. (QNCX)?

  • Healthcare Investors: Make informed decisions with a reliable analysis of therapeutic innovations.
  • Biotech Analysts: Streamline your research with comprehensive data on drug development and market potential.
  • Consultants: Efficiently modify reports and presentations tailored to client needs in the biotech sector.
  • Medical Professionals: Enhance your knowledge of cutting-edge therapies and their implications for patient care.
  • Students and Educators: Utilize as a resource for understanding biotechnology and pharmaceutical industry dynamics.

What the Template Contains

  • Historical Data: Includes Quince Therapeutics’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Quince Therapeutics’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Quince Therapeutics’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.